Skip to main content
SOLV logo

Solventum Corporation

SOLVNYSEHealthcareMedical Instruments & Supplies

$85.41Today:- (-)1Y +21.00%

As of Oct 23, 2026 close

Market cap
$14.80B
P/E (TTM)
10.32
Forward P/E
5.34
Dividend yield
-
52-week range
$62.38$94.16
Volume (live)
-
Avg. volume (3M)
928.79K

Solventum Corporation (SOLV) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Solventum Corporation stock.

Analyst Consensus Rating

Investment consensus from 12 professional research analysts

Consensus Rating

Buy
Based on 12 unique analysts
(15 total ratings in last 90 days)
High Confidence8.0:1 Buy/Sell

Average Price Target

$98.50
+15.33% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest SOLV Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Ryan Zimmerman
BTIG
BuyMaintains
$95.00
Travis Steed
BofA Securities
HoldReiterates
$95.00
Rick Wise
Stifel Nicolaus
BuyMaintains
$100.00
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Jason Bednar
Piper Sandler
BuyReiterates
$105.00
Ryan Zimmerman
BTIG
BuyReiterates
$95.00
Harshit Gupta
Zacks Equity Research
SellInitiates Coverage
-
Patrick Wood
UBS
BuyReiterates
$101.00
Vik Chopra
BMO Capital
HoldMaintains
$84.00
Travis Steed
BofA Securities
HoldMaintains
$20.00 → $95.00
Michael Piccolo
Wedbush
BuyReiterates
$94.00 → $101.00
Steven Valiquette
Mizuho
BuyMaintains
$100.00 → $113.00
Brett Fishbin
KeyBanc
BuyMaintains
$93.00 → $102.00
Nathan Treybeck
Wells Fargo
HoldMaintains
$70.00 → $89.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 21, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for SOLV?

The analyst consensus rating for SOLV is Buy, based on the latest ratings from 12 analysts over the last 90 days.

What is the average price target for SOLV?

The average 12-month price target for SOLV is $98.50, representing an upside of 15.3% from the Oct 23, 2026 close of $85.41.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.